Global Immunomodulators Market - Global Opportunity Analysis and Industry Forecast, 2021-2028

Immunomodulators are chemicals that reduce the immune system's ability to produce antibodies or sensitised cells, therefore altering the immunological response. The antigen that triggered their synthesis is recognised and reacted to by these cells. Corticosteroids, thymosin, cytotoxic drugs, and immunoglobulins are examples of immunomodulators. Some immunomodulators are derived from pharmaceutical preparations, while others are found naturally in the body.

The increasing use of monoclonal antibodies to treat disorders such as multiple sclerosis, Crohn's disease, rheumatoid arthritis, and others, as well as the increased prevalence of cancer, are two important reasons driving market expansion. Furthermore, the market's expansion is fueled by the availability of an effective product pipeline from firms working in immunomodulator R&D.

However, the existence of stringent regulations governing the approval process for immunomodulator antibodies makes it difficult for small-scale manufacturers to enter the market, and the scarcity of tumour necrosis factor (TNF) inhibitors, as well as the high costs associated with them, act as market restraints. Furthermore, increased awareness of the availability of such immunomodulators is expected to present the market with lucrative growth possibilities.

The immunomodulators market is segmented by product, application, and region in this analysis. The market is divided into immunosuppressants and immunostimulants based on the product. The market is divided into antibodies, calcineurin inhibitors, glucocorticoids, antimetabolites, and others based on immunosuppressants.

The market is divided into vaccinations, antibodies, and other immunostimulants. The market is divided into oncology, respiratory, human immunodeficiency virus (HIV), and other applications. The market has been studied across North America, Europe, Asia-Pacific, and Latin America and the Caribbean.

F. Hoffmann-La Roche Ltd., Amgen, Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., and Biogen Inc. are among the market's major players.